These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 10391057

  • 1. [Effect of prokinetic drugs inhibiting dopaminergic system on gallbladder motility in subjects with duodenal ulcer].
    Szabelska K, Chojnacki J, Grzegorczyk K, Mamos A.
    Pol Merkur Lekarski; 1999 Apr; 6(34):188-91. PubMed ID: 10391057
    [Abstract] [Full Text] [Related]

  • 2. Metoclopramide improves gastric but not gallbladder emptying in cardiac surgery patients with early intragastric enteral feeding: randomized controlled trial.
    Sustić A, Zelić M, Protić A, Zupan Z, Simić O, Desa K.
    Croat Med J; 2005 Apr; 46(2):239-44. PubMed ID: 15849845
    [Abstract] [Full Text] [Related]

  • 3. [The effect of domperidone and metoclopramide on antral motility (author's transl)].
    Schmidt GF, Engel T, Bauer H, Doenicke A.
    Anaesthesist; 1978 Sep; 27(9):427-9. PubMed ID: 362981
    [Abstract] [Full Text] [Related]

  • 4. Dopaminergic modulation of rectosigmoid motility: action of domperidone.
    Wiley J, Owyang C.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):548-51. PubMed ID: 3612550
    [Abstract] [Full Text] [Related]

  • 5. Clinical application of an enzyme immunoassay for cholecystokinin-like immunoreactive substance for determination of the human plasma levels: the effect of metoclopramide on gastrointestinal peptides and stress-related hormones.
    Katagiri F, Inoue S, Itoh H, Takeyama M.
    J Pept Sci; 2006 May; 12(5):311-20. PubMed ID: 16245263
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B, Greving I.
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [Abstract] [Full Text] [Related]

  • 7. [Effects of dopamine D2 receptor antagonists on gastrointestinal motility].
    Mizumoto A, Ito A.
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):65-9. PubMed ID: 2273688
    [No Abstract] [Full Text] [Related]

  • 8. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F, Foullioux C, Pacheco B, Maroun C, Bolívar H, Lares M, Leal E, Cano R, Bermúdez V, Velasco M.
    Am J Ther; 2008 Apr; 15(4):397-402. PubMed ID: 18645345
    [Abstract] [Full Text] [Related]

  • 9. [Current role of antidopaminergic drugs in pediatrics].
    Cinquetti M, Bonetti P, Bertamini P.
    Pediatr Med Chir; 2000 Apr; 22(1):1-7. PubMed ID: 11387760
    [Abstract] [Full Text] [Related]

  • 10. Dopamine antagonists in the upper gastrointestinal tract.
    Valenzuela JE, Dooley CP.
    Scand J Gastroenterol Suppl; 1984 Apr; 96():127-36. PubMed ID: 6382574
    [Abstract] [Full Text] [Related]

  • 11. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M, Luchsinger A.
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [Abstract] [Full Text] [Related]

  • 12. Control of gastroduodenal coordination: dopaminergic and cholinergic pathways.
    Schuurkes JA, Van Nueten JM.
    Scand J Gastroenterol Suppl; 1984 Jan; 92():8-12. PubMed ID: 6146199
    [Abstract] [Full Text] [Related]

  • 13. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA.
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [Abstract] [Full Text] [Related]

  • 14. [From clinical action to the elucidation of mechanism of action: 20 years of research on Primperan].
    Quivy F.
    Pathol Biol (Paris); 1987 Sep; 35(7):1099-100. PubMed ID: 3313219
    [Abstract] [Full Text] [Related]

  • 15. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
    Corazza GR, Biagi F, Albano O, Bianchi Porro G, Cheli R, Mazzacca G, Miglio F, Naccarato R, Quaglino D, Surrenti C, Verme G, Gasbarrini G.
    Ital J Gastroenterol; 1996 Sep; 28(6):317-23. PubMed ID: 8891846
    [Abstract] [Full Text] [Related]

  • 16. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
    Maddern GJ, Kiroff GK, Leppard PI, Jamieson GG.
    J Clin Gastroenterol; 1986 Apr; 8(2):135-40. PubMed ID: 3745846
    [Abstract] [Full Text] [Related]

  • 17. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
    Miyazawa T, Matsumoto M, Kato S, Takeuchi K.
    Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
    [Abstract] [Full Text] [Related]

  • 18. Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
    Forte P, Martin G, Luchsinger A, Hernandez O, Romero E, Velasco M.
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):404-6. PubMed ID: 8225687
    [Abstract] [Full Text] [Related]

  • 19. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT, Lee YJ, Chung SJ, Shim CK.
    Res Commun Mol Pathol Pharmacol; 2000 Aug; 108(5-6):311-23. PubMed ID: 11958284
    [Abstract] [Full Text] [Related]

  • 20. Domperidone, a new dopamine antagonist.
    Champion MC, Hartnett M, Yen M.
    CMAJ; 1986 Sep 01; 135(5):457-61. PubMed ID: 3527396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.